Table 2. Overall prevalence of comorbidities, in the group admitted to the ICU and in the fatal cases by COVID-19.
| Comorbidity | Overall Prevalence | ICUs Patients | Fatal Cases | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| PP | 95% CI | W % | PP | 95% CI | W % | PP | 95% CI | W % | |
| Hypertension | 32 | 31 - 33 | 6.54 | 27 | 25 - 29 | 6.86 | 35 | 31- 38 | 8.10 |
| Chronic Heart Disease | 13 | 13 - 14 | 6.62 | 18 | 18 - 19 | 7.15 | 17 | 14 - 20 | 8.61 |
| Diabetes | 22 | 21 - 23 | 6.57 | 17 | 15 -19 | 7.17 | 19 | 16 - 22 | 8.53 |
| Malignancy | 3 | 3 - 4 | 6.68 | 5 | 4 - 6 | 7.81 | 5 | 4 -7 | 9.22 |
| COPD | 8 | 7 - 8 | 6.65 | 7 | 6 - 8 | 7.67 | 9 | 7 -11 | 9.03 |
| Asthma | 3 | 3 - 3 | 6.69 | 0 | 0 - 0 | 0.00 | 0 | 0 - 0 | 0.00 |
| Chronic Kidney Disease | 5 | 5 - 5 | 6.67 | 5 | 6 - 8 | 7.81 | 4 | 3 - 6 | 9.29 |
| Chronic Liver Disease | 2 | 1- 2 | 6.7 | 2 | 4 - 6 | 8.01 | 3 | 2 - 4 | 9.42 |
| Cerebrovascular Accident | 2 | 1- 3 | 6.7 | 1 | 1 - 2 | 8.05 | 6 | 5 - 9 | 9.15 |
| Immunodeficiency | 2 | 2 - 3 | 6.69 | 2 | 1 - 3 | 7.97 | 0 | 0 - 0 | 0.00 |
| Autoimmune Disease | 0 | 0 - 0 | 6.71 | 0 | 0 - 0 | 8.12 | 0 | 0- 1 | 9.57 |
| Cardiovascular and Cerebrovascular Accident | 1 | 1 - 1 | 6.71 | 0 | 0 - 0 | 0.00 | 0 | 0 - 0 | 0.00 |
| Digestive Disease | 0 | 0 - 0 | 6.71 | 0 | 0 - 1 | 8.11 | 0 | 0 - 1 | 9.60 |
| Peripheral Vascular Disease | 0 | 1 - 0 | 6.71 | 0 | 0 -0 | 8.12 | 0 | 0 - 0 | 0.00 |
| Other | 8 | 7 - 8 | 6.65 | 18 | 16 - 19 | 7.15 | 2 | 1 - 3 | 9.48 |
|
| |||||||||
| Overall | 7 | 5 - 8 | 100 | 7 | 6 - 8 | 100 | 9 | 6 - 11 | 100 |
ICU = Intensive Care Unit; PP = Pooled Prevalence; W = Weight; COPD = Chronic Obsctructive Pulmonary Disease; CI = Confidence Interval.